Clarke, Christopher James
- Stony Brook University · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #15,996
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$709.1K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#15,996
By linked amount among FY2023 PIs
Earliest Year Loaded
2021
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Clarke, Christopher James as a PI. Multi-PI records show the full award amount for context.
- 5R01CA248080-03R01Contact PINeutral sphingomyelinase-2 as a mediator of Doxorubicin-induced cardiotoxicityStony Brook University · Internal Medicine (NIH department code)$354.5Kaward amount
- 5R01CA248014-03R01Contact PIDihydroceramide desaturase (DES1) as a mediator of receptor tyrosine kinase-driven metastasis in breast cancerStony Brook University · Internal Medicine (NIH department code)$354.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing Clarke, Christopher James as a PI.
FY2023 award administered by Stony Brook University (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardStony Brook University
- 2021$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022R01 Grant Holder
- 2023$2M Cumulative Funding